test

BRIANNE SHERGILL

@Exome Asset Management Llc

Latest period2024 - Q3ReportedManaged Assets$293.574MTotal holdings59
Assets growth rate161.38%Assets growth rate (2-Q avg)78.78%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Exome Asset Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 59 positions.

Assets under management

The assets under management (AUM) of Exome Asset Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 293.574M in assets, with a quarterly growth rate of 161.38% and a 2-quarter average growth rate of 78.78%. The portfolio is managed by BRIANNE SHERGILL, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
4857⤦Karyopharm Therapeutics Inc
Recent Activity
New Position
1.04%
$3.04M
4M shares@ $0.76 avg price
STAAStaar Surgical Co
Recent Activity
New Position
1.04%
$3.031M
81,600 shares@ $37.15 avg price
TARSTarsus Pharmaceuticals Inc
Recent Activity
New Position
1.03%
$3M
91,200 shares@ $32.89 avg price
BCRXBiocryst Pharmaceuticals Inc
Recent Activity
New Position
1.02%
$2.987M
393,000 shares@ $7.6 avg price
SRRKScholar Rock Hldg Corp
Recent Activity
New Position
0.76%
$2.23M
266,078 shares@ $8.39 avg price
TECXTectonic Therapeutic Inc
Recent Activity
Increased 124.43%
0.76%
$2.202M
72,688 shares@ $30.3 avg price
QTRXQuanterix Corp
Recent Activity
Increased 146.45%
0.65%
$1.905M
147,002 shares@ $12.97 avg price
ACRVAcrivon Therapeutics Inc
Recent Activity
New Position
0.56%
$1.635M
233,514 shares@ $7.0 avg price
LXEOLexeo Therapeutics Inc
Recent Activity
New Position
0.55%
$1.594M
176,296 shares@ $9.05 avg price
VYNEVyne Therapeutics Inc
Recent Activity
Increased 100%
0.46%
$1.329M
706,868 shares@ $1.89 avg price